HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olli Vapalahti Selected Research

21-fluoro-16-ethyl-19-norprogesterone (FENP)

1/2020Streptococcus halichoeri: Comparative Genomics of an Emerging Pathogen.
8/2017Questionnaire survey of detrimental fur animal epidemic necrotic pyoderma in Finland.
1/2016Experimental Infection of Mink Enforces the Role of Arcanobacterium phocae as Causative Agent of Fur Animal Epidemic Necrotic Pyoderma (FENP).
1/2014Characterization of a new epidemic necrotic pyoderma in fur animals and its association with Arcanobacterium phocae infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olli Vapalahti Research Topics

Disease

46Infections
06/2022 - 07/2002
18Hantavirus Infections
01/2022 - 03/2003
8COVID-19
01/2022 - 11/2020
7Virus Diseases (Viral Diseases)
01/2021 - 10/2005
5Hemorrhagic Fever with Renal Syndrome (HFRS)
01/2022 - 10/2004
4Pyoderma
01/2020 - 01/2014
4Tick-Borne Encephalitis (Encephalitis, Tick Borne)
07/2019 - 09/2003
3Vesicular Stomatitis
01/2020 - 01/2016
3Flavivirus Infections
01/2019 - 06/2014
3Communicable Diseases (Infectious Diseases)
01/2016 - 08/2012
3Japanese Encephalitis
12/2013 - 09/2012
2Inflammation (Inflammations)
01/2021 - 11/2020
2Hepatitis
01/2020 - 08/2003
2Hemorrhage
12/2019 - 07/2002
2Coinfection
01/2019 - 11/2018
2Zika Virus Infection
01/2018 - 03/2017
2Tick Bites
01/2018 - 05/2008
2Arthritis (Polyarthritis)
01/2016 - 01/2008
2Dengue (Dengue Fever)
11/2014 - 01/2010
2Cowpox
04/2014 - 11/2003
1Proteinuria
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
12/2021
1Fatigue
12/2021
1Mental Fatigue
12/2021
1Tuberculosis (Tuberculoses)
04/2021
1Convalescence
01/2021
1Reinfection
01/2021
1Encephalitis (Encephalitis, Rasmussen)
11/2020
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020
1Otitis
01/2020
1Wounds and Injuries (Trauma)
12/2019
1Chronic Disease (Chronic Diseases)
11/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019
1Autoimmune Diseases (Autoimmune Disease)
03/2018

Drug/Important Bio-Agent (IBA)

20AntibodiesIBA
05/2021 - 09/2003
15Immunoglobulin M (IgM)IBA
01/2020 - 03/2003
13Proteins (Proteins, Gene)FDA Link
06/2022 - 12/2007
13VaccinesIBA
01/2022 - 05/2008
13AntigensIBA
01/2021 - 07/2002
11Immunoglobulin G (IgG)IBA
11/2019 - 11/2003
10RNA (Ribonucleic Acid)IBA
11/2018 - 10/2005
5Viral RNAIBA
01/2022 - 07/2008
5Antiviral Agents (Antivirals)IBA
01/2021 - 03/2017
421-fluoro-16-ethyl-19-norprogesterone (FENP)IBA
01/2020 - 01/2014
4Glycoproteins (Glycoprotein)IBA
01/2019 - 06/2008
4HLA Antigens (Human Leukocyte Antigens)IBA
01/2019 - 10/2004
3Peptide Hydrolases (Proteases)FDA Link
06/2022 - 08/2021
3Neutralizing AntibodiesIBA
01/2022 - 01/2021
3EpitopesIBA
01/2019 - 06/2014
3Complement System Proteins (Complement)IBA
11/2018 - 08/2012
3Peptides (Polypeptides)IBA
03/2018 - 06/2014
3EnzymesIBA
02/2008 - 03/2003
2mRNA VaccinesIBA
01/2022 - 01/2021
2Phosphotransferases (Kinase)IBA
10/2021 - 08/2021
2apilimodIBA
10/2021 - 08/2021
2Pharmaceutical PreparationsIBA
10/2021 - 08/2021
2CathepsinsIBA
10/2021 - 08/2021
2nafamostatIBA
10/2021 - 08/2021
2camostatIBA
10/2021 - 08/2021
2CytokinesIBA
01/2021 - 01/2020
2AutoantibodiesIBA
01/2019 - 08/2012
2SuspensionsIBA
10/2017 - 01/2017
2obatoclaxIBA
03/2017 - 10/2012
2saliphenylhalamideIBA
03/2017 - 10/2012
2GemcitabineFDA Link
03/2017 - 10/2012
2NucleoproteinsIBA
01/2017 - 01/2015
2Viral AntigensIBA
08/2012 - 07/2002
2DNA (Deoxyribonucleic Acid)IBA
08/2011 - 01/2011
2Caspase 8 (Caspase-8)IBA
03/2005 - 11/2004
12019-nCoV Vaccine mRNA-1273IBA
01/2022
1BNT162 VaccineIBA
01/2022
1Immune Sera (Antisera)IBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1heparanaseIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Apolipoproteins E (ApoE)IBA
12/2021
1ApolipoproteinsIBA
12/2021
1Apolipoprotein E4IBA
12/2021
1Virulence Factors (Pathogenicity Factors)IBA
04/2021
1Pimozide (Orap)FDA Link
01/2021
1CitalopramFDA LinkGeneric
01/2021
1HLA-DR Antigens (HLA-DR)IBA
01/2021
1Antipsychotic Agents (Antipsychotics)IBA
01/2021
1Antidepressive Agents (Antidepressants)IBA
01/2021
1Imipramine (Janimine)FDA LinkGeneric
01/2021
1Fluoxetine (Prozac)FDA LinkGeneric
01/2021
1Reboxetine (Vestra)IBA
01/2021
1Chemokine ReceptorsIBA
01/2021
1Flupenthixol (Flupentixol)IBA
01/2021
1Chlorpromazine (Thorazine)FDA Link
01/2021
1SARS-CoV-2 spike proteinIBA
01/2021
1Blood Proteins (Serum Proteins)IBA
11/2020
1Toll-Like Receptor 3IBA
11/2020
1enhanced green fluorescent proteinIBA
01/2020
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2019
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2019
1Testosterone (Sustanon)FDA Link
10/2018

Therapy/Procedure

3Therapeutics
01/2022 - 03/2017
1Critical Care (Surgical Intensive Care)
12/2021
1Personal Protective Equipment
12/2019